“In silico Study of New Five-Membered Heterocyclic Derivatives Bearing (1,3,4-oxadiazole and 1,3,4-thiadiazole) As Promising Cyclooxygenase Inhibitors”, AJPS, vol. 24, no. 3, pp. 237–251, Jul. 2024, doi: 10.32947/ajps.v24i3.1060.